Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
AbbVie signs heavily backloaded $2.1B Xilio biobucks pact in Big Pharma's latest T-cell engager deal
Fierce Biotech
Wed, 02/12/25 - 10:05 am
AbbVie
Xilio Therapeutics
T-cell engager
FDA approves AbbVie-Pfizer's treatment for intra-abdominal infections
MSN/Reuters
Sun, 02/9/25 - 04:28 pm
AbbVie
FDA
intra-abdominal infections
Emblaveo
With uncertainty roiling Big Pharma, execs are placing lower-risk bets
Pharma Voice
Fri, 02/7/25 - 11:16 am
Big Pharma
JNJ
AbbVie
Novartis
Merck
Pfizer
earnings
AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
Yahoo Finance
Fri, 01/31/25 - 11:23 am
AbbVie
earnings
Skyrizi
Rinvoq
AbbVie pulls off a hat trick with 3rd straight year as top TV drug ad spender, buoyed by Skyrizi and Rinvoq spots
Fierce Pharma
Thu, 01/23/25 - 12:00 pm
AbbVie
TV ads
DTC advertising
Skyrizi
Rinvoq
AbbVie Teams Up With Neomorph for Molecular Glue Collab Worth up to $1.64B
BioSpace
Thu, 01/23/25 - 11:47 am
AbbVie
Neomorph
molecular glue
molecular glue degraders
JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson
BioPharma Dive
Fri, 01/17/25 - 11:30 am
JPMHC 2025
AbbVie
Eli Lilly
JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized hole
Clinical Trials Arena
Wed, 01/15/25 - 11:54 pm
JPMHC 2025
AbbVie
Skyrizi
Rinvoq
Humira
JPM25: AbbVie pens $1B deal for Simcere’s phase 1 T-cell engager
Fierce Biotech
Mon, 01/13/25 - 11:11 am
AbbVie
JPMHC 2025
Simcere
T-cell engager
ALS drugs from Denali, Calico come up short, marking more failures for Healey trial
BioPharma Dive
Tue, 01/7/25 - 11:42 am
Denali Therapeutics
AbbVie
Calico Life Sciences
ALS
clinical trials
AbbVie exercises first $40 million option to advance Capsida-partnered CNS gene therapy
Fierce Biotech
Tue, 01/7/25 - 11:35 am
Capsida Biotherapeutics
AbbVie
neurodegenerative disease
AbbVie’s tavapadon achieves positive topline results in Phase III TEMPO-2 trial
Clinical Trials Arena
Wed, 12/18/24 - 11:20 am
AbbVie
clinical trials
tavapadon
Parkinson's Disease
3 closely watched drugs that failed in the clinic
Pharma Voice
Mon, 12/16/24 - 11:24 am
biotech
Roche
tiragolumab
AbbVie
emraclidine
Cassava Sciences
simufilam
AbbVie to acquire Roche spinout Nimble in immune drug deal
BioPharma Dive
Fri, 12/13/24 - 11:49 am
AbbVie
Nimble Therapeutics
M&A
IL-23
Roche
AbbVie's Parkinson's prospect hits again in phase 3, completing clean sweep to tee up FDA filing
Fierce Biotech
Mon, 12/9/24 - 11:09 am
AbbVie
Parkinson's Disease
tavapadon
FDA
Alector lays off 17% of staff after AbbVie-partnered Alzheimer's asset fails phase 2
Fierce Biotech
Tue, 11/26/24 - 11:05 am
Alector
AbbVie
Alzheimer's disease
clinical trials
layoffs
AL002
What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
Pharma Voice
Tue, 11/19/24 - 10:57 am
AbbVie
R&D
virology
AbbVie bags EU nod for key drug from ImmunoGen takeover
Pharmaphorum
Mon, 11/18/24 - 11:10 am
AbbVie
Europe
Elahere
ovarian cancer
Immunogen
Advantage BMS as AbbVie drug fails schizophrenia trials
Pharmaphorum
Mon, 11/11/24 - 11:24 am
AbbVie
emraclidine
schizophrenia
Cerevel Therapeutics
clinical trials
Bristol Myers Squibb
Among 2024’s modest M&A action, cancer, immunology and neuroscience deals trickle in
Pharma Voice
Thu, 11/7/24 - 11:12 am
M&A
Vertex Pharmacuticals
Alpine Immune Sciences
Eli Lilly
Morphic
Novartis
MorphoSys
Mariana Oncology
AstraZeneca
Fusion Pharmaceuticals
Lundbeck
Longboard Pharmaceuticals
AbbVie
Aliada Therapeutics
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »